A detailed history of Lpl Financial LLC transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Lpl Financial LLC holds 195,513 shares of PACB stock, worth $351,923. This represents 0.0% of its overall portfolio holdings.

Number of Shares
195,513
Previous 201,442 2.94%
Holding current value
$351,923
Previous $275,000 20.73%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$1.2 - $2.17 $7,114 - $12,865
-5,929 Reduced 2.94%
195,513 $332,000
Q2 2024

Aug 07, 2024

BUY
$1.36 - $3.65 $28,274 - $75,883
20,790 Added 11.51%
201,442 $275,000
Q1 2024

May 10, 2024

BUY
$3.52 - $9.59 $1,679 - $4,574
477 Added 0.26%
180,652 $677,000
Q4 2023

Feb 14, 2024

BUY
$5.97 - $10.36 $28,918 - $50,183
4,844 Added 2.76%
180,175 $1.77 Million
Q3 2023

Nov 13, 2023

BUY
$8.23 - $13.93 $167,776 - $283,976
20,386 Added 13.16%
175,331 $1.46 Million
Q2 2023

Jul 31, 2023

SELL
$9.97 - $14.05 $55,403 - $78,075
-5,557 Reduced 3.46%
154,945 $2.06 Million
Q1 2023

May 10, 2023

SELL
$7.94 - $12.02 $354,632 - $536,861
-44,664 Reduced 21.77%
160,502 $1.86 Million
Q4 2022

Feb 07, 2023

SELL
$5.67 - $11.2 $49,703 - $98,179
-8,766 Reduced 4.1%
205,166 $1.68 Million
Q3 2022

Nov 14, 2022

BUY
$3.93 - $8.57 $48,916 - $106,670
12,447 Added 6.18%
213,932 $1.24 Million
Q2 2022

Aug 12, 2022

BUY
$4.02 - $10.43 $282,425 - $732,759
70,255 Added 53.54%
201,485 $891,000
Q1 2022

May 16, 2022

BUY
$8.43 - $20.9 $257,932 - $639,477
30,597 Added 30.4%
131,230 $1.19 Million
Q4 2021

Feb 14, 2022

BUY
$19.26 - $30.08 $405,134 - $632,732
21,035 Added 26.43%
100,633 $2.06 Million
Q3 2021

Nov 15, 2021

BUY
$24.86 - $35.02 $4,425 - $6,233
178 Added 0.22%
79,598 $2.03 Million
Q2 2021

Aug 13, 2021

BUY
$22.3 - $36.02 $798,607 - $1.29 Million
35,812 Added 82.12%
79,420 $2.78 Million
Q1 2021

May 14, 2021

SELL
$26.38 - $51.15 $2,295 - $4,450
-87 Reduced 0.2%
43,608 $1.45 Million
Q4 2020

Feb 12, 2021

BUY
$10.5 - $28.5 $220,342 - $598,072
20,985 Added 92.4%
43,695 $1.13 Million
Q3 2020

Nov 09, 2020

BUY
$3.61 - $9.87 $11,136 - $30,448
3,085 Added 15.72%
22,710 $224,000
Q2 2020

Aug 13, 2020

BUY
$2.65 - $4.03 $52,006 - $79,088
19,625 New
19,625 $68,000
Q3 2019

Nov 13, 2019

SELL
$4.99 - $6.16 $141,466 - $174,636
-28,350 Closed
0 $0
Q2 2019

Aug 09, 2019

BUY
$5.92 - $7.41 $47,360 - $59,280
8,000 Added 39.31%
28,350 $172,000
Q1 2019

May 08, 2019

BUY
$6.8 - $7.4 $138,380 - $150,590
20,350 New
20,350 $147,000
Q4 2018

Feb 07, 2019

SELL
$3.99 - $7.82 $92,149 - $180,602
-23,095 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$3.52 - $5.55 $8,465 - $13,347
2,405 Added 11.62%
23,095 $125,000
Q2 2018

Aug 14, 2018

BUY
$2.11 - $3.92 $43,655 - $81,104
20,690 New
20,690 $73,000
Q4 2017

Feb 14, 2018

SELL
$2.59 - $5.44 $104,506 - $219,504
-40,350 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$3.2 - $5.57 $8,800 - $15,317
2,750 Added 7.31%
40,350 $212,000
Q2 2017

Aug 14, 2017

BUY
N/A
37,600
37,600 $134,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $405M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.